Description
HUMA Peptide CJC-1295 DAC 2 mg is a premium research peptide formulated with CJC-1295 DAC (Drug Affinity Complex), a long-acting analogue of Growth Hormone Releasing Hormone (GHRH) extensively studied for its prolonged interaction with growth hormone signaling pathways. Designed for advanced peptide research, CJC-1295 DAC has become a cornerstone in scientific investigations involving endocrine regulation, hormone secretion, metabolic physiology, and peptide pharmacokinetics.
Each pack contains 5 lyophilized vials, with 2 mg of CJC-1295 DAC per vial, offering researchers a convenient multi-vial format for extended laboratory studies. Manufactured to exceptional quality standards, HUMA Peptide CJC-1295 DAC delivers superior purity, stability, and consistency, making it an excellent choice for professionals conducting advanced peptide and endocrine research.
With its extended-duration profile and research-grade quality, HUMA Peptide CJC-1295 DAC provides a reliable foundation for exploring hormone regulation, receptor biology, peptide interactions, and cellular signaling mechanisms in controlled scientific environments.
Key Features
- Premium CJC-1295 DAC (Drug Affinity Complex) research peptide
- 2 mg of high-purity peptide per vial
- 5 lyophilized vials per pack
- Long-acting Growth Hormone Releasing Hormone (GHRH) analogue
- High-purity research-grade formulation
- Commonly studied in growth hormone and endocrine pathway research
- Suitable for investigations involving hormone regulation and peptide pharmacology
- Manufactured under strict quality standards
- Intended exclusively for laboratory and scientific research applications
Contents
Active Ingredient: CJC-1295 DAC (Drug Affinity Complex) – 2 mg
Packaging: 5 Lyophilized Vials
Reviews
There are no reviews yet.